10.2165/00044011-200525060-00005 Clin Drug Investig
Its levels tend to decrease with age, chronic illness, and poor health
PCSK9 is secreted by the liver and it binds to LDL-LDL receptor complexes on hepatocytes which, following endocytosis, stimulates the lysosomal degradation of the LDL receptor (LDLR), thereby reducing the recycling of the LDLR to the plasma membrane
(Note: This product appears as a distinctive blue cake due to the high copper content of GHK-Cu)
Two weeks ago, the Chairman of the society wrote to the Chief Medical Officers and the relevant Ministers for Health in each of the constituent countries in the UK, pointing out that the injections were not a cosmetic treatment but were required to prevent nerve damage or worse from happening
Call or message us at (786) 502-2260 to schedule your BPC-157 consultation with a licensed medical provider